16.07.2019 • NewsDede WillamsLanxess

Lanxess‘ new Prepolymers Unit on Stream in Brazil

Lanxess‘ new Prepolymers Unit on Stream in Brazil (c) Lanxess
Lanxess‘ new Prepolymers Unit on Stream in Brazil (c) Lanxess

The Urethane Systems business unit of German specialty chemicals producer Lanxess recently started up a new production unit for of high performance prepolymers at its site in Porto Feliz, Brazil, thereby expanding overall output capability. Application development and technical services are also being provided from a state-of-the-art laboratory at the site.

Markus Eckert, Head of the Urethane Systems business unit, said Lanxess is “committed to the Brazilian and South American market.” With the new facilities, he said, the company’s global and local customers will be able to profit from faster supply as well as engineering and technical services.

With expertise in cast elastomers, coatings, adhesives and sealants, the Cologne-based chemical producer is a systems provider to the global PU industry. Its portfolio includes conventional and low free isocyanate prepolymers and special aqueous polyurethane dispersions (PUDs). Catalysts and curing agents for cast elastomers, along with technologies for coatings, adhesives and sealants, round out the offerings.

For the company as a whole, Lanxess’ special focus is on solvent-free and monomer-free prepolymer systems, as well as easy-to-use blocked crosslinkers. The Urethane System business operates production facilities and application development centers in all major economic regions, including Brazil, the US, India, China, Australia, Italy and the UK.

 

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.